Linvoseltamab,REGN5458,Elotuzumab,Pomalidomide,Dexamethasone
Regeneron,regeneron,AbbVie,BMS
['linker-mm1', 'linvoseltamab', 'linker,mm,3', 'mmsm']
#eha2023 | hans c. lee presents data from the phase 2 linker-mm1 trial of dosing for linvoseltamab in rrmm. orr was 71% vs 50% in the 200mg and 50mg cohorts, respectively. crs was the most common teae, in 45% and 55% in 200mg and 50mg. #mmsm #myeloma 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma